Web Chat to Focus on New Alzheimer’s Study Results

July 22, 2004

            New research about a potential treatment for the agitation that many patients with dementia experience will be discussed in a web chat Friday, July 23, at http://www.urmc.rochester.edu/alzheimerschat.

            The chat, hosted by the University of Rochester Medical Center, will focus on new results announced today at the 9th International Conference on Alzheimer’s Disease and Related Disorders in Philadelphia. A large study led by Pierre Tariot, M.D., professor of Psychiatry, Medicine, and Neurology, showed that a drug commonly used to treat schizophrenia and other psychotic disorders appears effective at reducing actions like shouting at or slapping caregivers. The medication tested in the study, quetiapine, was effective at treating agitation, but with fewer side effects than other medicines that doctors turn to now.

            The results of the study were chosen by the Alzheimer’s Association, which sponsors the meeting, as one of the most newsworthy findings presented at the conference.

            The chat will take place Friday, July 23, from 2:30 to 3:15 p.m. Anyone interested in learning more about what the findings mean for patients and families who have been affected by Alzheimer’s disease is invited to participate.

For Media Inquiries:
Public Relations Department
(585) 275-3676
Email Public Relations